0001847173-21-000002.txt : 20210303 0001847173-21-000002.hdr.sgml : 20210303 20210303140839 ACCESSION NUMBER: 0001847173-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210303 DATE AS OF CHANGE: 20210303 EFFECTIVENESS DATE: 20210303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Excision BioTherapeutics Inc CENTRAL INDEX KEY: 0001847173 IRS NUMBER: 473658697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-391112 FILM NUMBER: 21708258 BUSINESS ADDRESS: STREET 1: 988 MARKET STREET, SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94102 BUSINESS PHONE: (404) 229-1162 MAIL ADDRESS: STREET 1: 988 MARKET STREET, SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94102 D 1 primary_doc.xml X0708 D LIVE 0001847173 Excision BioTherapeutics Inc 988 MARKET STREET, SECOND FLOOR SAN FRANCISCO CA CALIFORNIA 94102 (404) 229-1162 DELAWARE None None Corporation true Daniel Dornbusch c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Executive Officer Director Vasudev Bailey c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Director William Carson c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Director Ashok Krishnamurthi c/o Excision BioTherapeutics Inc 988 Market Street, Second Floor San Francisco CA CALIFORNIA 94102 Director Biotechnology Decline to Disclose 06b false 2021-02-16 false true true true Offering of convertible promissory notes ("Notes") and the underlying shares of equity securities issuable upon conversion of the Notes. false 1 10500000 10500000 0 false 6 0 0 0 false Excision BioTherapeutics Inc /s/ Daniel Dornbusch Daniel Dornbusch Chief Executive Officer 2021-03-03